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Quality assurance of pharmaceutical distributors is essential in the pharmaceutical product 
handling from the manufacturer to the patient as the end user. The Health Authority being the 
Pharmacy and Poisons Board has been instrumental in ensuring that the pharmaceutical 
distributor is well regulated through issuance of licenses for operation after an assessment.  
However, the distribution system in Kenya remains exposed to the risk of poor-quality 
medicines if the quality assurance is not observed or maintained. The study sought to determine 
the factors affecting quality assurance of pharmaceutical distributors in the county of Nairobi. 
The specific objectives were to determine the role of management commitment, customer 
focus and continuous improvement on quality assurance of pharmaceutical distributors in 
Nairobi County. A descriptive research design was adopted and the targeted population was 
the quality assurance managers of the 186 registered pharmaceutical distributors in Nairobi 
County. The analyst utilized a stratified random sampling strategy to come up with 74 
respondents, which constituted the sample size. The research utilized primary data in form of 
questionnaires and comprised of both close and open-ended questions. The research chose 18 
persons as the pilot group from the population of target. Analysis of data was carried out by 
employing Microsoft Excel and SPSS by the use of means, percentages and frequencies. A 
multivariate regression model assisted in establishing the relationship amongst the studied 
factors. In Conclusion, the pharmaceutical distributors had codes of practice in place regarding 
employees involved in the distribution of pharmaceutical products and budget for quality 
assurance aspects. The pharmaceutical distributors had enhanced customer satisfaction through 
timely delivery of customer products and responding to product quality defects. The 
pharmaceutical distributors had made innovations and improvements to their facilities and 
processes to ensure quality assurance was achieved. More funds should be allocated towards 
enhancing management commitment as a recommendation. Pharmaceutical distributors should 
continue ensuring customer satisfaction through timely delivery of customer products, timely 
response to customer complaints, offering quality services and quick response to product 
quality defects. Pharmaceutical distributors should improve the quality assurance by allocating 
more funds, developing well elaborate procedures, automation of processes, putting in place 
checks and balances and implementing recommendations of the Pharmacy and Poisons Board. 
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CHAPTER ONE: INTRODUCTION 
1.1 Introduction  
The overriding theme of this study is establishing factors affecting quality assurance of 
pharmaceutical distributors in Nairobi County. This chapter outlines the background to the 
study, definition of the problem, objectives of this research, research questions, scope of the 
research study and significance of this study. 
1.2 Background to the Study 
Clients are becoming more aware of the increasing standards in the quality of pharmaceutical 
products, having exposure to a broad range of alternatives. There happens to be an ever rising 
quality demand on services or products where the international revolution makes firms to make 
investments in resources that are substantial in implementation of whole quality management 
(Joshi and Shekhar in 2011). To better a firm’s competitiveness, firms are searching for top 
level success in all processes and functions and the firms happen to be making quality 
assurance an approach to sustain themselves in the business (Christos & Evangelos, 2010). 
Dale in 2010 accentuated that constant advancement in overall activities of a business with the 
target on a client accentuates on the quality and the flexibility through which firms encounter 
threat are competitive. That is the reason the management, quality and linked constant 
improvement happen to be searched by a big number of firms as a way of surviving and 
maintaining competitiveness over competitors (Ustadh, 2012). 
Quality is achieved when customers implied and articulated needs are met fully. This statement 
happens to be core from where other well-known quality definitions are obtained. They consist: 
the entirety of characteristics and attributes of a service or a product which stands on it’s 
potential in meeting an implied or articulated want, conforming to the need and suitability for 
usage (Sharma & Kodali, 2008). Its key to point out that meeting the expectations and the 
wants of a client is the major element in every of the descriptions. Thus, it is vital for a firm to 
recognize such like wants in advance in the service or the product cycle of development. The 
potential to accurately describe the wants associated with design, delivery, performance, 
safety, price and some more business operations will put an organization above their rivals in 
the same market. Quality happens to be an integrated system of strategy aimed at attaining the 
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satisfaction of clients, which consists of employees and their managers and applied quantitative 
approaches to consistently improve the processes of an organization (Ugboro & Obeng, 2010).  
World Health Organization (WHO) describes QA as being a widespread idea sheltering all 
concerns, which collectively or individually affect the product’s quality. It is the total sum of 
every plan with a goal to make sure of quality pharmaceutical products as needed for the 
desired use. QA thus adopts Good Manufacturing Practices (GMP) as well as other 
components, counting the ones that are not within this scope like product development and 
designing (WHO, 2017). Concerning the pharmaceuticals, QA could be categorized into 4 
main areas; quality production, control, inspections and distribution. The guidelines, norms 
and standards development to enhance QA is a key section of the constitution of WHO and is 
supported and endorsed by many resolutions of World Health Assembly. Making sure that 
manufacturing, packaging, storing of pharmaceuticals in an environment that is not 
contaminated is a key necessity in the process of QA. The World Health Assembly 
incorporated numerous solutions and most currently in the Medicines Strategy of WHO from 
2008 to 2013 requiring the firm to establish global standards, instruments and 
recommendations to guarantee the medicine’s quality whether nationally or globally produced 
and sold (WHO, 2017). 
WHO describes best practices of distribution as being a portion of QA which makes sure that 
pharmaceutical product’s quality is paid attention to within sufficient ways of sufficient control 
of many operations happening in the course of the process of distribution and also offering an 
instrument to keep safe the system of distribution from unapproved, unlawfully imported, 
counterfeit, misbranded, adulterated and substandard products (WHO, 2017). WHO pointed 
out that pharmaceutical products that are counterfeit exist and are a threat to the health and the 
safety of the public. Therefore, it is key to guard the chain of supply of the pharmaceutical 
products to prevent entry of those bad products into the market. Weak distribution points of 
the products aid for entrance of counterfeit, stolen, unlawfully imported as well as substandard 
pharmaceutical products in the chain of supply through which those products are entering the 
chain of supply happen to increase day by day and results to establishment of successful grey 
and secondary markets in the entire world. The participation of entities that do not have 
authority to sell and distribute pharmaceutical products happens to be a major concern. Just a 
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mutual methodology consisting all players comprised in the chain of supply may be effective 
in the war against pharmaceutical products that are counterfeit and, thus, all players who are 
acting in that market are supposed to play actively in cooperative activities (WHO, 2015). 
WHO recommends that every player concerned in distributing the pharmaceutical products is 
responsible of ensuring maintenance of integrity in the chain of distribution as well as 
distributing quality products. National legislation is supposed to be in place to control the 
operations of firms or persons partaking in the distribution of pharmaceutical products. All 
workers that are in the activity of distribution are supposed to be qualified and well trained on 
the needs of best practices of distribution. Rules are supposed to enhance a secure, transparent 
and safe system of distribution that comprises traceability of products in the whole chain of 
supply. There is supposed to be best practices in the storing and distribution of pharmaceutical 
products. The storing and distribution of Pharmaceutical products is supposed to be shipped in 
containers that have no hostile impacts on product quality. Selling and distribution of 
Pharmaceutical products is supposed to be done by authorized individuals or firms to get those 
products (WHO, 2015). 
The Kenyan Pharmaceutical sector comprises of 4 sections namely retailers, hospitals, 
distributors and the manufacturers, that play a key function to support the sector of health in 
the nation. The Kenyan Pharmaceutical sector is mainly by Distributor Imports although there 
are local manufacturing sites. Asoko Visions has recognized forty-five registered 
manufacturers on pharmaceutical manufacturers by KPPB (Kenya Pharmacy and Poisons 
Board, 2017). Kenya has a substantial number of multinationals such as Astra Zeneca, 
GlaxoSmithKline and Novartis amongst others who import pharmaceutical products into the 
market. Amongst the top local manufacturers are Lab &Allied Limited, Universal Corporation 
Limited, Dawa Limited and Cosmos Limited. In 2016, there were 186 registered 
pharmaceutical distributors and approximately 700 registered wholesalers in Kenya, operated 
by pharmaceutical technologists and pharmacists who are registered, based on the medical 
directory Kenya Pharm Tech. The biggest distributor of the pharmaceutical products happens 
to be Kenya Medical Supplies Authority (Kenya Pharmacy and Poisons Board, 2017). 
Pharmaceutical distributors therefore, mainly stock products from local manufacturers such as 
Cosmos, Regal, Beta Ltd and/or import from generic manufacturers such Getz Pharma, Cipla, 
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Intas and/or original/ branded manufacturers/ multinationals such as Novartis, Roche, Astra 
Zeneca, GSK. The Distributors store and distribute pharmaceutical products as per the Good 
Storage Practices and Good Distribution Practices as dictated by the WHO guidelines on Good 
Manufacturing Practices. Essentially the WHO Guidelines provides standards to ensure 
product integrity from the manufacturer right to the pharmacy level before the patient who in 
this case is the end user is prescribed the drug. WHO Guidelines therefore, has the GxP 
practices which guides handling of pharmaceutical products. The x can be replaced with M in 
case of manufacturing such that it becomes GMP- Good Manufacturing Practices which 
included Good Storage Practices and Good Distribution Practices Authority (Kenya Pharmacy 
and Poisons Board, 2017). 
As a requirement by the KPPB, the Pharmaceutical Distributors should be licensed in order to 
operate. Before obtaining the license, the company should be assessed/ inspected by a member 
of KPPB to ascertain that they meet the minimum required standards of maintaining product 
integrity during storage and distribution of pharmaceutical products. The same assessment is 
also performed by branded companies such as Novartis before a commercial contract or 
agreement is signed in order to supply their pharmaceutical products. Quality Assurance is 
therefore essential from a Health Authority and Multinational perspective (Kenya Pharmacy 
and Poisons Board, 2017). 
The Pharmacy and Poisons Board is committed to its mission to ensure the availability of 
pharmaceutical services in Kenya which satisfy the needs of all for the prevention, diagnosis 
and treatment of diseases using safe, efficacious, high quality and cost-effective 
pharmaceutical products. Pursuant to this mission, it is imperative that pharmaceuticals are 
distributed by highly qualified personnel through outlets that are duly licensed and 
professionally run. The operations in those premises should at all times be supervised by 
qualified personnel and the risk of exposing the public to unsafe medicines avoided at all cost. 
Guidelines have been prepared to provide distributors of pharmaceutical fraternity with a 
method of assessing eligibility and the process of lawfully operating drug distribution outlets 
Kenya Pharmacy and Poisons Board, 2017). 
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1.3 Problem Definition 
Quality assurance of pharmaceutical distributors is essential in the pharmaceutical product 
handling from the manufacturer to the patient as the end user. However, the distribution system 
in Kenya remains exposed to the risk of poor-quality medicines if the quality assurance is not 
observed or maintained (Wangai, 2015). The major distributors in Kenya such as Kenya 
Medical Supplies Authority (KEMSA) employ good distribution practices to enhance quality 
assurance of their products. Lack of quality assurance implementation amongst Pharmaceutical 
Distributors may lead to poor-quality medicines in the market. The pharmaceutical distributors 
rarely use a strict criterion in the selection of suppliers and products. Thus, product quality may 
not be reliably assured as it depends on the requirements of suppliers (Kenya Pharmacy and 
Poisons Board, 2017). 
The suppliers perform QA audits according to certain aspects that need to be implemented such 
as capital intensive items: refrigeration, generators as power back up, temperature mapping, 
installation of Air Conditioning units to maintain temperature in the warehouse, owning 
refrigerated vehicles, monitoring temperature of products to the customer during transport etc 
but these quality aspects do not directly translate to a return on investment as the generic 
companies and local manufacturers do not perform QA audits on the same distributors who 
equally store and distribute their products. These Quality aspects are emphasized by 
multinationals before they accept to supply the distributor with their products for sale (Wangai, 
2015).  
Enhancement of quality assurance in the pharmaceutical drug distribution system could 
translate into return on its investment and customer satisfaction. Ndjamawe (2012) studied 
quality assurance and issues of safety of the pharmaceutical products advertised in developing 
nations and noted that the distribution of medicines that are substandard continues to be a 
critical problem in Africa’s Sub-Saharan region whereby numerous drugs accessible happen 
to be imported. Locally, Cheroigin (2014) focused on total quality management and 
performance of multinational pharmaceutical firms in Nairobi, Kenya and it was noted that if 
TQM is well implemented it can meet the customers’ needs, improve internal communication 
and better problem-solving capacity of the firm. The above studies focused on the total quality 
management which is different from quality assurance thus our study was different as it 
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focused on the factors affecting quality assurance in pharmaceutical distributors in Nairobi so 
as to fill the gap. 
1.4 Research objectives 
1.4.1 General Objective 
The general objective of the study was to determine the factors affecting quality assurance of 
pharmaceutical distributors in the county of Nairobi.  
1.4.2 Specific Objective 
The following objectives of this research guided the study: 
i. To determine the role of management commitment on quality assurance of 
pharmaceutical distributors in Nairobi County. 
ii. To evaluate the effect of customer focus on quality assurance of pharmaceutical 
distributors in Nairobi County. 
iii. To assess the effect of continuous improvement on quality assurance of pharmaceutical 
distributors in Nairobi County. 
1.5 Research Questions 
i. What is the effect of management commitment on quality assurance of pharmaceutical 
distributors in Nairobi County? 
ii. To what extent does customer focus affect quality assurance of pharmaceutical 
distributors in Nairobi County? 
iii. What is the effect of continuous improvement on quality assurance of pharmaceutical 
distributors in Nairobi County? 
1.6 Scope of the study 
This study focused on the factors affecting quality assurance in pharmaceutical distributors in 
Nairobi County. The primary data was collected from the quality assurance managers of the 
186 registered pharmaceutical distributors in Nairobi County and the study covered a period 
of five months. 
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1.7 Significance of the study 
The study may have significant value for policy makers and development partners who lend a 
hand in the growth of distribution pharmaceutical companies. Regarding, total quality 
management and quality assurance, policies and regulations can be implemented to boost and 
stimulate both factors. The study sets to benefit the owners and managers of distribution 
pharmaceutical companies as they may appreciate the benefit of adopting various total quality 
management practices that may enable them improve the quality assurance of their processes. 
This may enable them continuously improve their products quality and standards in order to 
meet customers’ expectations and thus enhance their competitiveness. The study maybe used 
by Pharmacy and Poisons Board, to improve the regulation of the pharmaceutical distributing 
industry in ensuring that organizations in the field implement total quality management 
practices so that the benefits can be passed on to the customers. The patients will also benefit 
as the end users since they will obtain efficacious products that are safe in that the quality of 
the product is maintained during storage and distribution. Scholars and researchers who might 
have an interest in developing the findings or undertaking research work in other related fields 





CHAPTER TWO: LITERATURE REVIEW 
2.1 Introduction 
This chapter looks at the literature that focuses on factors affecting quality assurance in 
pharmaceutical distributors in Nairobi County. It also entails conceptual framework and 
theoretical framework. The empirical review also addresses on the different studies conducted 
under this field. 
2.2 Theoretical Review 
The section discusses and explains the role of total quality management on quality assurance 
of pharmaceutical distributors in Kenya. The theories discussed are the theory of Quality 
Improvement, Constraints theory and Resource-Based View.  
2.2.1 Quality Improvement Theory 
This theory suggests that a component of quality management places duty concerning 
fabricating associations decisively at the door of the highest administration (Deming, 1986). 
This hypothesis gives an expression that an administration is in charge of the frameworks, and 
the framework yields 80% of the firm issues (Hill & Wilkinson 1995). Deming in 1986 
identified there would be no essence of quality framework of the administration in absence of 
duty of the highest; the administration places procedures on resources, makes corporate 
culture, chooses providers and grows long haul connections. Deming's theory of Quality 
Improvement gives enterprises a plan of taking out low issues on quality control by effective 
systems of administration.  
Hubert in 2000 brought forward the theoretical approach by Deming in 1986 regarding 
substantial administration framework and it envisages production of a hierarchical framework 
which encourages taking part and thinking of ways of encouraging the process implementation 
that the administration rehearses. This, therefore, encourages the determined change in items, 
procedures as well as administration effects on the fulfilment of a worker. These happen to be 
typical to bettering the center of clients and then aiding in existence of associations. The 
hypothetical quintessence of the theory on Quality Improvement paid attention in the worries 
of quality in coming up with an influential framework that encourages learning and 
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participation for heartening the use of process administration rehearses, that, thus, encourages 
implementation (Anderson, Daly & Johnson, 1994). Oakland (2004) focused on that 
obligations of highest administration ought to control the pack in the frameworks and 
procedures of changes. Administration shoulders a critical section in assuring the achievement 
of value administration because the highest administration's duty of making and imparting the 
dream to move the entity toward change execution. The quality improvement theory advocates 
that for there to be quality assurance there must be continuous improvement of the processes 
and distribution systems in the organization and thus supports the objective of the study on the 
role of management commitment and continuous improvement on quality assurance of 
pharmaceutical distributors in Nairobi County. 
2.2.2 Resource-Based View  
This emphasizes on the assets of the association as being the important determining factors of 
implementation and competitive advantage. It incorporates 2 beliefs in flouting down 
competitive advantage (Barney in 2001). The model agrees that firms within an industry could 
be heterogeneous concerning assets controlled by the firm. Secondly, it agrees that 
heterogeneity of assets can hold on after a duration on the basis that assets applied in executing 
schemes of a firm happen not to be mobile across organizations. Asset heterogeneity is viewed 
as an important condition for an asset package to add to competitive advantage. The Resource-
Based View Theory is to a great extent in light of behavioral and sociological worldview and 
considers organizational variables and their fit with the world as the significant determinants 
of progress (Barney, 2001).   
Because assets reflect various capable components, this research similarly focuses on 
ramifications of performance of other internal characteristics of firms (Barney, 2001), for this 
instance organization’s capacities, tireless change and customer centeredness. Dissimilarly, the 
typical argument of this theory is the fact that non-substitutable, matchless and uncommon 
assets brings about a firm’s heterogeneity, and the fact that productive entities happen to be 
the ones that obtain and shield important and incredible assets to miss which result to a firms 
decent implementation resulting from the sustainable upper hand which develops (DiMaggio 
and Powell, 1991). The readiness of a firm discovers the kind of value frameworks to be 
searched for, because the assets which a certain association possesses will greatly affect the 
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functions or non-functions of the entity. The main objective of RBV stems from generating 
competitive advantage that enables companies to obtain quality assurance levels based upon 
their respective combination of resources and capacities which focuses on the need of the 
customers and thus supports the objective of the study on the effect of customer focus on 
quality assurance of pharmaceutical distributors in Nairobi County. 
2.3 Empirical Literature 
The section gives an insight on literature from previous scholars concerning the factors 
affecting quality assurance.  
2.3.1 Management Commitment 
Bhaskar, Sanjib and Abhishek (2016) focused on management commitment in pharmaceuticals 
in India. Purposive sampling was used and the self-administered questionnaire, semi-structured 
interviews and focus group discussion guide were used. It was noted that execution of a 
successful policy on quality assurance happens to be a key significant goal in the 
pharmaceutical sector. The concept of quality assurance and quality control together develops 
towards assuring the quality, effectiveness and safety of the pharmaceutical products. 
Therefore, quality happens to be a vital component towards the effectiveness of a firm in the 
recent world that may be attained by management commitment, a firm’s methodology which 
aims at quality as being an over-arching objective, focused at mitigating effects as compared 
to detecting them.  
Sudhanshu (2015) evaluated the impacts of management commitment on how Indian 
Pharmaceutical sectors performed. This survey got carried out through the issue of a self-
designed questionnaire and distributed to choose Indian pharmaceutical firms. Management 
commitment operates as a shelter where everybody in a firm may work towards satisfaction of 
the needs of a client, cut down the wastage and expenses and raise services efficiency. It then 
was pointed out that the highest management leadership, commitment, quality management, 
customer focus, employee training and best relationships with the vendors and suppliers were 




Adza (2016) focused on examining practices of management commitment on performance of 
an organization in Intravenous Infusions Limited Koforidua. Collection of primary data was 
carried out by the use of a structured and properly designed questionnaire that included close 
and open-end questions. The management commitment execution is at the level of quality 
assurance. It then got discovered that the indecisions of the management lowered the 
commitment of leadership towards quality and made practices of management commitment 
unsuccessful. A conclusion was then arrived at that there had a need to obtain modern tools for 
boosting production. Management should work at building trust between the members of staff 
to better the team work.  
Monirei in 2016 focused on management commitment and organizational performance of 
manufacturing firms in Nairobi County. The research design used was descriptive and 
inferential statistics method. It was noted the effective execution of the substantial programs 
relied on the workers. If the industry of manufacturing could have more training, participating 
and empowering the workers it’s quite probable to get more benefit over technique on quality 
management. Further implementation and adoption of other practices on quality management 
for instance ISO 9000 and contrast challenges and benefits of the practices of quality 
management. 
2.3.2 Customer Focus 
Sadik (2018) focused on the impact of customer focus on customer satisfaction (e-services) a 
descriptive research was undertaken and questionnaires were used as the instruments for the 
study. It was noted that implementation of customer focus would change the market and 
organizations in future. It would help in achieving organizational goals. It would also help the 
customers to achieve customer satisfaction and understanding. There would be management 
commitment of the employees with the organization. If all the system of the organization work 
in a quality management and in a systematic way then this all will ultimately result in better 
customer and supplier relationship. 
Cheroigin (2014) examined customer focus an element of TQM and how multinational 
pharmaceutical companies based in Nairobi performed. This study incorporated a descriptive 
research design. Collection of data was done by the use of self-administered questionnaires. It 
got discovered that in the case where there was customer focus; it yields a number of benefits 
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like satisfying the wants of clients, advanced communication and increased capacity of the 
company to solve problems. It was also found that effectiveness of customer focus program 
rises where its execution is cascaded down the whole employee’s cadre since it needs the 
improvement of the culture of corporates and infusion of fresh philosophy of business in the 
firm. 
In determining customer focus and TQM and the performance of pharmaceutical 
manufacturing and distributing in terms of quality assurance in entities situated in Kenya, 
Wangai (2015) adopted a cross sectional survey and systematic random sampling method was 
used. The measures of performance were both financial and non-financial and included stock 
turns, equipment effectiveness, people productivity, delivery schedule achievement, value 
added per person and profitability. Data collected was analyzed by use of descriptive statistics 
using SPSS. The study found that customer focus greatly affected performance of 
pharmaceutical manufacturing and distribution firms in Kenya. Results established the 
existence of a positive association amongst customer focus and performance of Kenyan 
pharmaceutical distribution and manufacturing firms.  
2.3.3 Continuous Improvement 
Esin and Hilal (2014) focused on the effects of continuous improvement and performance of 
firms in Turkey where a cross-sectional survey methodology was used and the unit of the 
sample was at the plant level. It was noted that firms should give necessary continue to 
improve through offering training to all their employees so as to improve their proficiencies in 
their tasks. Effective continuous improvement in quality bring success for the firms. 
Employees’ effective knowledge and learning capability will provide sustainability of quality 
management in the firm. Furthermore, learning organizations adapt rapidly to the changes and 
develop unique behavior, which distinguishes them from other firms and enables them to 
obtain better results. Quality does not begin in one department or function; it is the 
responsibility of the whole firm. Training should be given to all employees based on the results 
of the training needs assessment. 
Kaziliunas (2010) focused on the effect of continuous improvement on quality assurance of 
firms in Malaysia, the study noted that success factors for continuous improvement of 
processes include top management improvement, improvement in reward systems, team, 
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motivational factors and education and training. The study findings deduced that there was a 
relationship between the values and requirements stated above, thus underpinning the quality 
assurance standard and organizations’ strategic dimensions. The study concluded that 
education and training of employees is another way of providing employees with the 
knowledge and skills to meet their overall work and personal objective. If carried out 
consistently and reinforced in the workplace by real-time updating, education and training, it 
can form a solid base for continuous improvement and hence quality assurance. 
Prajogo and Sohal (2014) conducted an empirical study on the multi-dimensionality of ISO 
practices in determining quality assurance of Australian firms. The basic proposition was 
whether ISO embodied two models of practices, mechanistic and organic, with each indicating 
a different impact in the association and with two different kinds of continuous improvement, 
on quality and on innovation. The researchers used some empirical data gathered from 
Australian firms and reported some evidence on the proposition upon pairing the mechanistic 
elements of ISO with quality assurance. The results of the implementation on Pearson 
Correlation Ratio had indicated that there were some positive and meaningful relationship 
between continuous improvement of ISO standard components and quality assurance.  
2.4 Summary of Research Gap 
From the evidence, many studies have been conducted on the effects of the factors affecting 
quality assurance but few have focused on the pharmaceutical distributors. Bhaskar, Sanjib 
and Abhishek (2016) focused on management commitment in pharmaceuticals in India and 
noted that execution of a successful policy on quality assurance happens to be a key significant 
goal in the pharmaceutical sector. This study was done in India which is a different context 
from Kenya in terms of development in technologies and innovations relating to the medical 
field. Monirei in 2016 focused on management commitment and organizational performance 
of manufacturing firms in Nairobi County and noted the organizational performance of the 
substantial programs relied on the management commitment. This study focused on 
manufacturing firms and it was broad in terms of organizational performance as quality 
assurance is a part of organizational performance.  
Sadik (2018) focused on the impact of customer focus on customer satisfaction and noted that 
implementation of customer focus would also help the customers to achieve customer 
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satisfaction and understanding. The above study focused on customer satisfaction and 
customer focus while this study seeks to focus on the role of customer focus in enhancing 
quality assurance. Taking into consideration that quality assurance of pharmaceutical 
distributors is essential in the pharmaceutical product handling from the manufacturer to the 
patient as the end user in order to preserve product integrity. This study thus seeks to fill the 
gap that exist by focusing on the factors affecting quality assurance of pharmaceutical 
distributors in Nairobi County. 
2.4 Conceptual Framework 
This alludes to the level by which a research is able to conceptualize as relationship amongst 
contextual variables during the research and illustrates that relationship in a diagram or a graph. 
This relationship gives a description of the link between independent and the dependent 
variables. 
Independent Variables     Dependent Variables 
            
            
            
            
            
            
            
            
            
            




Figure 2.1: Conceptual Framework 
Source: Author (2018)   
Customer Focus  
 Customer verification process 
 Method of handling customer 
complaints 
 Type of distribution system 
Management Commitment  
 Organization structure 
 Codes of operations 
 Segregation of duties 
    
Quality Assurance  
 Defect prevention 
 Quality of products 
 Quality of services 
Continuous Improvement 
 Audits and evaluation 
 Evaluation of suppliers 





2.4.1 Management Commitment 
Management commitment for it to be successful change in the culture of an organization and 
this may only be attainable having a deep attention or participation of the management towards 
the strategy of the organization concerning constant advancements, coordination and 
transparent communication in the entire firm. Implementation of MC betters the performance 
of a firm through the influence of other dimensions of MC (Kaynak in 2013). Evans and 
Lindsay in 2013 suggest that being successful in the promotion of success and efficiency of a 
business, MC should begin from the top, that is the CEO. Ellram and Cooper in 2013 regarded 
leadership being important towards implementing change in the organization most particularly 
in sectors of bettering the relations with the people who supply to them and the rest in the 
delivery chain. The leadership commitment of the strategy of MC as indicated in everyday 
work disposition is likely to take long to motivate workers to submit services of good quality 
which are beyond the clients’ anticipation. Oakland in 2013 pointed out that MC 
implementation needs a transparent long-term commitment of leadership. Oakland in 2013 
accentuated the management essence in offering a client targeted system of support like the 
recognition, measurements and awards for meeting clients with a goal to build a significant 
relation with clients.  
2.4.2 Customer Focus 
Happens to be a concept aimed at meeting the needs of clients. Therefore, a big number of 
firms will do their best to satisfy or even go beyond the expectation of clients in the root of 
their day to day operations and in the long-run (Andrle, 2014). TQM needs firms to grow a 
client targeted process of operations while obligating resources which position clients and 
satisfy their anticipation being an asset to the firm’s betterment of their financial performance. 
Forza and Filippini in 2015 gave an explanation that its key for a firm to keep a close relation 
with the clients so as to be aware of what they need and evaluate how effective it has been in 
satisfying the needs of clients.  
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2.4.3 Continuous Improvement 
This alludes to continuous assessment of administrative and technical processes while 
searching better approaches (Fuentes-Fuentes in 2014). TQM consists of the design in the 
production process, a constant improvement system. Oakland in 2013 suggested that the 
attention on constant betterment will result to quality assurance by information of a difficult 
team whereby membership is measured by their job on the comprehensive comprehension of 
the procedure, and their ability to take improvement action’. TQM has concerns in every 
production process, from planning levels and making decisions to work execution by the staff 
at the front line. The belief underlying constant betterment is typically the concept that errors 
may be mitigated and also having to prevent defects from occurring. Stahl in 2015, suggests 
that constant advancement alludes to constant improvement and refinement of the system of 
the organization, the services and goods of the firm to produce better value for clients. Then 
he outlined explained that the continuous look for ways in improving quality of product or 
service in the absence of customers complain may prevent a future problem. The constant 
process of improvement focuses on identifying and eliminating the roots of errors so as to curb 
them from occurring again. 
2.4.4 Quality Assurance 
Oakland in 2015 described quality assurance widely as avoidance of heavy problems by use of 
systematic and planned operations that involves documentation. This happens to be a belief 
underlying designing the production process of an enterprise with the goal to cut down the 
opportunities of yielding goods that are substandard. Cooper and Dale in 2014 suggest that 
quality assurance refers to a system that is prevention grounded that betters the quality of a 
service or a product with a rise in yields through accentuating on process redesigning, service 
and product. It stresses prevention of defects, as compared to quality controls that aims at 
detecting defects after production of an item. Quality assurance targets on preventing yielding 
of products that are non-consistent and places much stress on operations concerning the 
production process. Therefore, it is the design of the management focused on quality controls 
at every production stage to stop the emergence of superior problems. The philosophy of 
quality assurance ranted that creation of quality is done at the stage of designing, not at the 
stage of control and the fact that problems linked to quality are as a result of improper designing 
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process. Lockwood in 2016 suggests that quality assurance that is effective, should consist of 
establishment of a fresh approach and philosophy to operate which seems practical as 
compared to responsive, which involves motivation and participation of people in the course 
of the process from every department.   
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CHAPTER THREE: RESEARCH METHODOLOGY 
3.1 Introduction 
This research methodology chapter gives a description of the different methodologies applied 
in data collection, procedures incorporated in carrying out this study, the methods applied in 
analyzing and interpreting the collected data. Particularly, it identified the research design, 
population of target, the sample design, the instrument of collecting data, pilot testing and data 
analysis methods. 
3.2 Research Design 
A descriptive research design was adopted that aim at determining the factors affecting quality 
assurance in pharmaceutical distributors in Nairobi. It was preferred for this research because 
it allowed the analysis of various variables at a go and allowed the researcher to give a 
description of conditions, variables and situations (Erik & Marko, 2011). The method selected 
allowed the researcher give a general view of the outcomes to a larger population.  
3.3 Population  
Garg and Kothari in 2014 points out that population is a group of properly defined classes of 
elements, individuals, events, households or a set of things under investigation. This 
description makes sure that the targeted population is homogeneous. Conversely, the 
population of target is the particular population over which the information intended will be 
gained from (Kothari & Garg, 2014). The targeted population was the quality assurance 
managers of the 186 registered pharmaceutical distributors in Nairobi County. The quality 
assurance managers were selected based on their awareness of the quality practices and the 
standards used by the pharmaceutical distributors.  
Table 3.1: Target Population 
Population Category  Population Frequency Percentage (%) 
Local companies 80   43.0 
Multinational companies 106               57.0 
Total  186  100.0 
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3.4 Sampling   
Marko and Erick (2011) states that sampling alludes the selection process of various 
individuals for the research in a manner that an individual mirrors a bigger group from where 
the individuals are selected. A sample alludes to a small class derived from the population 
available. Sampling method is the procedure used by a researcher in gathering things, places 
or people for study (Kombo & Tromp, 2006). As per Mugenda and Mugenda (2008) for 
descriptive studies 10% - 20% of the total target population is adequate for the study. A 40% 
sample of the total population is considered sufficient and was therefore used to come up with 
74 respondents which constituted the sample from the target population of the 186 respondents. 
The analyst utilized a stratified random sampling strategy since the study population is not 
homogenous and, in this way, it is conceivable to isolate this population into strata for inducing 
a sample that is representative. Marko and Erik in 2011, pointed out that stratified random 
sampling methods is preferred as they are able to give an estimate of the population under 
study with better precision and provides a sample which mirrors the population the most. 
Table 3.2: Sample Size 
Population Category  Sample Size Percentage (%) 
Local companies 32  43.0 
Multinational companies 42  57.0 
Total  74 100.0 
 
3.5 Data Collection Methods 
The research utilized primary data in form of questionnaires. Questionnaires in descriptive 
statistics need few resources (cost, time and staff) and are fit to best produce primary 
information (Cooper & Schindler, 2011). The researcher had a letter of introduction from 
Strathmore University to guarantee respondents confidentiality of the information provided 
and will only be applied for purposes of research when performing actual data collection. 
Administration of self-administered questionnaires was carried out by use of the drop and pick 
method. The researcher also used email and made phone calls to reach the respondents to 
ensure a high response rate. 
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The questionnaires comprised of both close and open-ended questions. Open-ended questions 
were employed in this research for purposes of enabling respondents respond to questions on 
their own terms. This also gave the researcher room to explore ideas that may not have been 
discussed, yet are important (Cooper & Schindler, 2011). The questions need to be well 
thought- out as well as contemplated from the respondent’s side and may consume more time 
to provide answers (Cooper & Schindler, 2011). 
Questions that were close-ended entailed mainly the likert scales and based on Schindler and 
Cooper in 2011, likert scales happen to very reliable and give increased data volumes as 
compared to the rest of the scales. They as well happen to be good in approximating the curve 
for normal curve of responses.  
3.6 Pilot Test 
The essence of pilot testing is establishing appropriateness and the accuracy of the instruments 
of research and the design. Schindler and Cooper (2011) agree that the essence of pilot testing 
is detecting the weaknesses existing in the design and incorporating and providing proxy for 
collection of data of a probability sample. The research conducted a pilot study to test the 
validity and reliability of the questionnaire. The research chose 18 persons as the pilot group 
from the population of target. Kothari in 2014 gave a recommendation that at least 10 per cent 
of the population in the pilot test is supposed to be represented therefore the selection of 18 
persons is regarded as a representative pilot. 
3.6.1 Reliability of Instruments 
The methodology of Cronbach alpha, that is grounded on the internal consistency, was 
employed in measuring data reliability. Cronbach’s alpha tests the mean of items measurable 
and their correlation. Total reliability of the scales of the current condition and the intended 
condition was measured by the Cronbach's alpha, that is supposed to be beyond 0.7 which is 
the level of reliability that is acceptable (Bryman & Bell, 2007).  
3.6.2 Validity of Instruments 
With regard to Johnson and Gill in 2008, validity refers to the level of representativeness of 
the items sampled to the content designed to be measured by the test. Content validity used in 
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this research is an examination of the level at which the collected data by use of specific 
instruments mirrors a specific content or domain of a specific concept. The pilot study allowed 
for familiarity of the study and the procedure of its administration and identification of items 
requiring modification. The outcomes assisted the research to find solution of inconsistencies 
resulting from instruments that ensured what is desired, is measured. 
3.7 Data Analysis and Presentation 
The collected data was both qualitative and quantitative. Descriptive statistics were used in 
analyzing the data both qualitatively and quantitatively. These consisted of median, modes, 
mode, percentages, tables and frequency distributions. Additionally, advance statistical 
approaches were taken into consideration (inferential statistics). Analysis of data was carried 
out by employing Microsoft Excel and SPSS by the use of means, percentages and frequencies. 
This produced quantitative reports. Tables were used in summarizing feedbacks for future 
analysis and enable comparison.  
Qualitative data analysis (QDA) alludes to procedures and processes which are employed to 
do data analysis and give some degree of description, interpretation or understanding. 
Typically, qualitative data happens in a simultaneous manner with the collection of data. For 
qualitative analysis of data was carried out by the application of content analysis and 
presentation of outcomes in pros form. Content Analysis was used in the analysis and 
interpretation of behavioral or verbal data.  
A multivariate regression model assisted in establishing the relationship amongst the studied 
factors. The study terms the method of regression as being important as a result of its potential 
in testing the kind of influence generated by the independent variables on dependent ones.  
Regression as well is capable of estimating the linear equation’s coefficients, comprising one 
or many independent variables, that best estimates the dependent variable’s value (Cooper & 
Schindler, 2011). The linear regression model was applied in assessment of the combined 
impact of 4 dependent and the independent variables. 
The regression model was as follows: 




Y = Quality Assurance 
X1= Management Commitment 
X2= Customer Focus 
X3= Continuous Improvement 
β0 = Constant Term; β1, β2 and β3 = Beta coefficients which was employed for measuring 
dependent variable’s sensitivity (Y) to a change in a unit of predictor variables. 
ε = Error term 
3.8 Ethical Considerations  
The consideration was offered to ethical concerns which might result in the course of 
addressing the objectives of the research. Participants’ rights on handling the questionnaires 
were respected. Accuracy and Integrity of collection of data was observed while handling 
respondents and as well as in the analysis and reporting of outcomes. Ethics clearance was 
provided by the Strathmore Review Ethics Committee on the Informed consent form issued to 
participants ahead of responding to the questionnaires. Thereafter, consent was obtained from 
the Education ministry to collect data through National Commission for Science, Technology 
& Innovation (NACOSTI). There was guarantee of participants’ confidentiality, Voluntary 
participation and anonymity. 
3.9 Dissemination of Study Results 
After finalizing the report, it was presented to Strathmore University where the thesis will be 
available on the Strathmore University online library portal. The thesis may assist other future 
researchers who wish to participate in the area of quality assurance get empirical data. The 
result findings were also given to the pharmaceutical distributors through email. Finally, it was 






CHAPTER FOUR: PRESENTATION OF RESEARCH FINDINGS  
4.1 Introduction 
The chapter gives a presentation of research outcomes according to the set objectives. The 
presentation of analyzed data was done in tables. 
4.1.1 Response Rate 
The research focused on 74 individuals as the samples. Based on those 74 sampled, 64 
participated in the research making a general rate of response of 86.5%. Table 4.3 gives a 
presentation of the rates of response. 
Table 4.1: Response Rate 
Response rate Frequency Percentage 
Questionnaires Distributed 74 100% 
Questionnaires completed 64 86.5% 
 
4.2 Demographic Information 
4.2.1 Age 
The study requested respondents to give an indication of their categories of age that were as 
given below 
Table 4.2: Age of Respondents 
Age category Frequency Percent 
Below 30 years 4 6.3 
31-40 years 33 51.6 
Above 40 years 27 42.2 
Total 64 100.0 
The outcomes reveal that a huge number of respondents (51.6%) were between 31 to 40 years, 
42.2% were above 40 years of age while 6.3% were below 30 years. Based on Kothari (2014) 
it is important to have all ages represented in order to have an overall view of every generation 




4.2.2 Gender of the Respondents 
The study sought the gender of the respondents. The findings are presented in Table 4.3 
Table 4.3: Gender of the Respondents 
Gender Frequency Percent 
Male 37 57.8 
Female 27 42.2 
Total 64 100.0 
The outcomes reveal that a number of respondents were male whereas 42.2% were female. 
The findings reveal that there was no gender bias. The above results would be due to there 
being a higher percentage of male pharmacists compared to female in Africa compared to a 
higher percentage of female pharmacists in the European and Eastern Mediterranean region. A 
higher percentage of male pharmacists is also seen in the Pan American region (Global 
Pharmacy Workforce and Migration Report, 2015). 
4.2.3 Highest Level of Education 
Table 4.4: Highest Level of education 
Level of education Frequency Percent 
Postgraduate 24 37.5 
Degree 40 62.5 
Total 64 100.0 
The outcomes reveal that a number of respondents (62.5%) were degree holders while 37.5% 
were postgraduates. The findings imply that respondents were well educated to respond to the 
study questions regarding quality assurance. The level of education plays a significant role in 
enhancing the competence of employees. In Kenya, pharmacists are required to have a 
minimum of diploma (Kenya Pharmacy and Poisons Board, 2017). However, the pharmacists 
are in managerial roles thus important for them to have either a degree or be post graduate 




4.2.4 Period Worked in The Organization 
The research aimed at finding out the respondents experience in their organizations. 
Table 4.5: Period Worked 
Period  Frequency Percent 
Less than 5 8 12.5 
5-10 years 38 59.4 
Over 10 years 18 28.1 
Total 64 100.0 
The outcomes reveal that a number of respondents had worked in the facility for a period of 5-
10 years, 28.1% for a duration above 10 years and 12.5% had an experience of below 5 years 
in the facility. The outcomes show that respondents had adequate experience in the respective 
organization to understand the status of quality assurance in their organization. Wangai (2015) 
noted that duration of existence in the pharmaceutical firm enhance the implementation of 
quality assurance. Employees who have been in operation for a longer period tend to gain 
greater benefits from understanding quality assurance practices. 
4.3 Management Commitment and Quality Assurance 
The study requested the respondents to indicate the challenges faced by the top management 
in enhancing the quality assurance of the products and services. From the findings, the 
respondents indicated that some employees are resistant, some employees lack the necessary 
skills, there are delays and shortages, financial constraints, poor implementation of the 
recommendations made and poor coordination within the management. The respondents, were 
then requested to give an indication of how much they agree with the statements that relate to 
effect of management commitment on quality assurance. The outcomes are as illustrated below 
Table 4.6: Influence of Management Commitment on Quality Assurance 
Statements N Min Max Mean Std. Deviation 
There is an organizational structure regarding the 
distribution of our pharmaceutical products 
64 1.00 4.00 1.906 0.526 
The employees’ responsibility participating in 
distribution of pharmaceutical products is clearly 
stated in a job description 
64 1.00 4.00 2.031 0.666 
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The authority of all personnel participating in 
distribution of pharmaceutical products is clearly 
stated 
64 1.00 3.00 2.266 0.718 
The interrelationships of all personnel participating in 
distribution of pharmaceutical products is clearly 
stated 
64 1.00 4.00 2.016 0.630 
There is a business continuity plan to mitigate 
contingencies and natural disasters such as fire 
64 1.00 3.00 1.938 0.302 
The distributor has a budget for Quality Assurance 
aspects such as redesigning the warehouse or 
investing in refrigerated vehicles 
64 1.00 3.00 1.875 0.766 
There is a code of practice in place regarding 
employees involved in the distribution of 
pharmaceutical products 
64 1.00 2.00 1.563 0.500 
The distributor conducts risk assessments for 
measuring the probable risks towards the quality and 
integrity of the pharmaceutical products 
64 1.00 4.00 1.891 0.475 
 
Based on the outcomes, majority of the respondents strongly agreed that a code of practice was 
in place regarding employees involved in the distribution of pharmaceutical products as 
indicated by a mean of 1.563 while the variation was small as indicated by standard deviation 
of 0.500. It was agreed that the distributor had a budget for quality assurance aspects such as 
redesigning the warehouse or investing in refrigerated vehicles as indicated by a mean of 1.875 
while the variation was small as indicated by standard deviation of 0.766. It was agreed that 
the distributor conducts risk assessments for measuring the probable risks towards the quality 
and integrity of the pharmaceutical products as indicated by a mean of 1.891 while the variation 
was small as indicated by standard deviation of 0.475. It was finally agreed that there was an 
organizational structure regarding the distribution of their pharmaceutical products as indicated 
by a mean of 1.906 while the variation was small as indicated by standard deviation of 0.526. 
Oakland (2013) earlier pointed out that MC implementation needs a transparent long-term 
commitment of leadership.  The interrelationships of all personnel participating in distribution 
of pharmaceutical products is clearly stated. 
The respondents further agreed that there was a business continuity plan to mitigate 
contingencies and natural disasters such as fire as indicated by a mean of 1.938 while the 
variation was small as indicated by standard deviation of 0.302.  It was agreed that the 
interrelationships of all personnel participating in distribution of pharmaceutical products was 
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clearly stated as indicated by a mean of 2.016 while the variation was small as indicated by 
standard deviation of 0.630. It was agreed that the employees’ responsibility participating in 
distribution of pharmaceutical products was clearly stated in a job description as indicated by 
a mean of 2.031 while the variation was small as indicated by standard deviation of 0.666. The 
respondents also agreed that the authority of all personnel participating in distribution of 
pharmaceutical products is clearly stated as indicated by a mean of 2.266 while the variation 
was small as indicated by standard deviation of 0.718. Consistent to the study findings, 
Sudhanshu (2015) found that management commitment, leadership, quality management and 
good supplier and vendor relationship were the most significant factors affecting quality 
assurance. Similarly, Rania and Samir (2015) found that there was significance influence of 
effective leadership on quality assurance. 
4.4 Customer Focus and Quality Assurance 
The study sought to find out in what ways the Pharmaceutical Distributors has enhanced 
customer satisfaction and met their expectation based on the services offered by the facilities. 
Based on the outcomes, respondents gave an indication that; they ensure timely delivery of 
customer products, timely response to customer complains, offering quality services, utilizing 
customer suggestion box, quick response to product quality defects and ensuring there are no 
counterfeits products.   
The respondents got a request to give an indication of how much they agreed with the 
statements below concerning how quality assurance was influenced by customer focus. The 
responses are as illustrated below 
Table 4.7: Influence of Customer Focus on Quality Assurance 
Statements N Min Max Mean Std. Deviation 
There is an existing documented procedure for handling 
complaints by customers 
64 1.00 2.00 1.922 0.270 
There is a customer suggestion box at the facility 64 1.00 3.00 2.109 0.567 
The is no supply or selling of pharmaceutical products 
ahead of authorization 
64 1.00 3.00 2.156 0.672 
There’s a process for quality auditing or  self-inspection 
which frequently assesses the success of the distribution 
system 
64 1.00 3.00 1.875 0.630 
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There exists a system that approves changes which might 
be having an effect on the quality of pharmaceutical 
products 
64 1.00 2.00 1.688 0.467 
There is a system present for recalling a batch of 
pharmaceutical products from supply or sale 
64 1.00 2.00 1.734 0.445 
We always examine the causes of substantial defects on 
pharmaceutical products 
64 1.00 2.00 1.766 0.427 
All measures and decisions made arising from a complaint 
are documented and then references made to the 
conforming batch numbers 
64 1.00 3.00 1.797 0.568 
Based on the outcomes, it was strongly agreed that there exists a system that approves changes 
which might be having an effect on the quality of pharmaceutical products as indicated by a 
mean of 1.688 while the variation was small as indicated by standard deviation of 0.467. It was 
strongly agreed that there was a system present for recalling a batch of pharmaceutical products 
from supply or sale as indicated by a mean of 1.734 while the variation was small as indicated 
by standard deviation of 0.445. It was strongly agreed that distributors always investigate the 
causes of quality defects on the pharmaceutical products as indicated by a mean of 1.766 while 
the variation was small as indicated by standard deviation of 0.427. It was strongly agreed that 
all measures and decisions made arising from a complaint were documented and then 
references made to the conforming batch numbers as indicated by a mean of 1.797 while the 
variation was small as indicated by standard deviation of 0.568. Stahl (2015) earlier revealed 
that the constant of ways of bettering service or product quality can curb the occurrence of a 
problem in future.   
The respondents further agreed that there’s was process for quality auditing or self-inspection 
which frequently assesses the success of the distribution system as shown by the mean 1.875 
while the variation was small as indicated by standard deviation of 0.630.  It was agreed that 
there was an existing documented procedure for handling complaints by customers as shown 
by the mean 1.922 while the variation was small as indicated by standard deviation of 0.270. 
It was agreed that there was a customer suggestion box at the facility as shown by the mean 
2.109 while the variation was small as indicated by standard deviation of 0.567.  It was agreed 
that there was no supply or selling of pharmaceutical products ahead of authorization as given 
by the mean of 2.156 while the variation was small as indicated by standard deviation of 0.672. 
Cheroigin (2014) found that performance and total quality management of the multinational 
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pharmaceutical entities is determined by customer focus through meeting the customers’ 
needs. 
4.5 Continuous Improvement and Quality Assurance 
The respondents were requested to indicate the innovations and improvements made to their 
facility and processes to ensure quality assurance is achieved. The respondents’ indicated they 
have adopted E-business, automated stock control, implemented electronic procurement 
system, regular employee training, technology adoption., have diverse designating systems and 
distribution control systems. The study made a request to respondents to give an indication of 
how much they agreed with statements that relate to influence of continuous improvement on 
quality assurance. 
Table 4.8: Influence of Continuous Improvement on Quality Assurance 
Statements N Min Max Mean Std. 
Deviation 
The Distributor undertakes quality audits and evaluation so 
as to enhance its quality assurance 
64 1.00 3.00 1.844 0.541 
There is a sectional department in place to assess the 
effectiveness of your distribution system 
64 1.00 4.00 2.219 0.701 
The Distributor evaluates the performance of suppliers so as 
to enhance its quality assurance 
64 1.00 3.00 2.203 0.622 
The Distributor undertakes regular trainings on employees so 
as to improve their skills and competences 
64 1.00 2.00 1.734 0.445 
Regular departmental and employee appraisals are carried out 
to measure employee performance 
64 1.00 3.00 2.016 0.488 
There is a system in place to reduce the number of quality 
defects resulting from transportation 
64 1.00 3.00 1.875 0.519 
 
Based on the outcomes, it was strongly agreed that a distributor undertakes regular trainings 
on employees so as to improve their skills and competences as given by the mean of 1.734 
while the variation was small as indicated by standard deviation of 0.445. It was agreed that 
the distributor undertakes quality audits and evaluation so as to enhance its quality assurance 
as given by the mean of 1.844 while the variation was small as indicated by standard deviation 
of 0.541. It was agreed that there was a system in place to reduce the number of quality defects 
resulting from transportation as given by the mean of 1.875 while the variation was small as 
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indicated by standard deviation of 0.519. Consistent to the findings Oakland (2013) found that 
the attention on constant improvement will result to quality assurance by information of a 
difficult team whereby membership is measured by their job on the comprehensive 
comprehension of the procedure. 
Further, it was agreed that regular departmental and employee appraisals were carried out to 
measure employee performance as given by the mean of 2.016 while the variation was small 
as indicated by standard deviation of 0.488. It was agreed that the distributor evaluates the 
performance of suppliers so as to enhance its quality assurance as given by the mean of 2.203 
while the variation was small as indicated by standard deviation of 0.622. Finally, it was agreed 
that there was a sectional department in place to assess the effectiveness of the distribution 
system as given by the mean of 2.219 while the variation was small as indicated by standard 
deviation of 0.701. Stahl (2015) established that continuous improvement was done thought 




4.6 Quality Assurance 
The respondents, were then requested to give an indication of ways in which they can enhance 
the quality assurance of the services and products offered at their facility. The respondents, 
indicated that that quality assurance of the services and products offered at their facility can be 
enhanced by allocating more funds, encourage top management support, employee training, 
development of well elaborate procedures, automation of processes, putting in place checks 
and balances, implementing recommendations of Pharmacy and Poisons Board, enhancing 
staff commitment having clear and direct procedures and improving quality of QA manual. 
The study made a request to respondents to give an indication of the relation of some aspect of 
quality assurance relate to their facility. The respondents’ levels of agreement were as in Table 
4.9 
Table 4.9: Aspect of Quality Assurance  
Aspects N Minimum Maximum Mean Std. Deviation 
Our company has a quality assurance manager 64 1.00 2.00 1.922 0.270 
Our company has a quality manual for 
implementing the QA programmes 
64 1.00 3.00 2.156 0.541 
Our company has developed the standard 
operating procedures (SOPs) 
64 1.00 4.00 2.031 0.470 
Management commitment is the key factor in 
enhancing quality assurance at the Distributor 
64 1.00 3.00 1.859 0.687 
Customer focus is the key factor in enhancing 
quality assurance at the Distributor 
64 1.00 2.00 1.750 0.436 
Continuous improvement is the key factor in 
enhancing quality assurance at the Distributor. 
64 1.00 4.00 1.938 0.560 
Based on the outcomes, it was strongly agreed that customer focus is the key element in 
enhancing quality assurance at the distributor as given by the mean of 1.750 while the variation 
was small as indicated by standard deviation of 0.436. It was agreed that the management 
commitment is the key factor in enhancing quality assurance at the distributor as given by the 
mean of 1.859 while the variation was small as indicated by standard deviation of 0.687. It was 
agreed that the companies had a quality assurance manager as given by the mean of 1.922 
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while the variation was small as indicated by standard deviation of 0.270. It was agreed that 
continuous improvement was the key factor in enhancing quality assurance at the distributor 
as given by the mean of 1.938 while the variation was small as indicated by standard deviation 
of 0.560. It was agreed that companies had developed the standard operating procedures 
(SOPs) as given by the mean of 2.031 while the variation was small as indicated by standard 
deviation of 0.470. Finally, it was agreed companies had a quality manual for implementing 
the QA programmes as given by the mean of 2.156 while the variation was small as indicated 
by standard deviation of 0.541. 
4.7 Inferential Statistics  
4.7.1 Model Summary 
The model summary sought to determine if the significance of the correlation coefficient at 
5% significance level as well as the extent that each independent variable explained the 
dependent variable through the coefficient of determination. 
Table 4.10: Model Summary 
Model R R Square Adjusted R Square Std. Error of the 
Estimate 
1 .583a .340 .307 1.40864 
a. Predictors: (Constant), total management commitment, customer focus, continuous 
improvement 
Adjusted R squared refers to a coefficient of determination that explains the dependent 
variable’s variation as a result of changes arising from the variables that are independent: Based 
on the outcomes above, the adjusted R squared value; 0.307 was an implication of presence of 
30.7% variation on the quality assurance as a result of changes in continuous improvement, 
customer focus and overall management commitment at 95% level of confidence. This implies, 
30.7% of changes in the quality assurance may be explained by the changes in continuous 
improvement, customer focus and overall management commitment. R refers to correlation 
coefficient that illustrates how the variables under study relate, based on the outcomes 
indicated in the above table there existed a positive relationship amongst the variables under 




4.7.2 Analysis of Variance  
This was tested so as to determine whether the model was significant at a 95% level of 
confidence. 
Table 4.11: ANOVA 
Model Sum of Squares df Mean Square F Sig. 
1 
Regression 61.382 3 20.461 10.312 .000b 
Residual 119.055 60 1.984   
Total 180.438 63    
a. Dependent Variable: quality assurance 
b. Predictors: (Constant), total management commitment, customer focus, continuous 
improvement 
Based on the analysis of ANOVA shown above, the data processed, that is the parameters of 
population, had a level of significance of 0.000 that implies the suitability of the data in coming 
up with a conclusion concerning the parameters of population as the significance value is 
below 5%.  The value of F critical was 2.758 at 5% significance level and three degrees of 
freedom whereas F calculated value was 10.312, because the value of F calculated was bigger 
than that of F critical, the entire model was deemed significant. 
4.7.3 Multiple Regression 
It was carried out in order to measure the level at which independent variables influenced the 
dependent ones.  
Table 4.12: Multiple Regression 
Model Unstandardized Coefficients Standardized 
Coefficients 
t Sig. 
B Std. Error Beta 
1 
(Constant) 1.351 0.331  4.082 0.000 
X1 0.574 0.181 0.556 3.171 0.002 
X2 0.598 0.1701 0.571 3.514 0.001 
X3 0.552 0.178 0.526 3.101 0.002 




Y=1.351+ 0.574 X1 + 0.598X2 + 0.552 X3+ ε 
Based on the above equation it got discovered that holding total management commitment, 
customer focus and continuous improvement to a constant zero, quality assurance of 
pharmaceutical distributors in Nairobi County could be 1.351. An increase by one unit in 
management commitment would result to a rise in the quality assurance by 0.574 units. A unit 
increase in customer focus would lead to an increase in quality assurance by 0.598 units. A 
increase by one unit in continuous improvement would lead to an increase in quality assurance 





CHAPTER FIVE: DISCUSSIONS, CONCLUSION AND RECOMMENDATIONS 
5.1 Introduction 
This chapter presents a summary of outcomes, the conclusion and study recommendations. 
The presentation is discussed as per the study objectives. 
5.2 Discussions 
5.2.1 Management Commitment and Quality Assurance 
The study’s first objective was to determine the function of management commitment on 
quality assurance of pharmaceutical distributors in Nairobi County. The findings revealed that 
there is a code of practice in place regarding employees participating in pharmaceutical 
products distribution, the distributor has a budget for quality assurance aspects such as 
redesigning the warehouse or investing in refrigerated vehicles and conducts assessments of 
risks for measuring the probable risks towards the integrity and quality of the pharmaceutical 
products. Oakland (2013) earlier pointed out that MC implementation needs a transparent long-
term commitment of leadership.  The interrelationships of all personnel participating in 
distribution of pharmaceutical products is clearly stated. Consistent to the study findings, 
Sudhanshu (2015) found that management commitment, leadership, quality management and 
good supplier and vendor relationship were the most significant factors affecting quality 
assurance.  
The research revealed that there are organizational structures regarding the distribution of 
pharmaceutical products and business continuity plans to mitigate contingencies and natural 
disasters such as fire. Cheroigin (2014) noted where there is proper implementation of TQM; 
it yields a number of benefits like satisfying the wants of clients, advanced communication and 
increased capacity of the company to solve problems. The employees’ responsibility 
participating in distribution of pharmaceutical products is clearly stated in a job description as 
well. The authority of all personnel participating in distribution of pharmaceutical products is 
clearly stated. Similarly, Rania and Samir (2015) found that there was significance influence 
of effective leadership on quality assurance. 
The research found that challenges faced by the top management in enhancing the quality 
assurance of the products and services are employees are resistant, lack the necessary skills, 
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delays and shortages, financial constraints, poor implementation of the recommendations made 
and poor coordination within the management. The above findings relate to quality 
improvement theory put across by (Deming, 1986) which suggest that continuous 
improvement gives an organization a plan of taking out low issues on quality control by 
effective systems of administration. Hence management commitment in terms of providing the 
resources necessary for enhancing quality assurance is key. The leadership commitment of the 
strategy of MC as indicated in everyday work disposition is likely to take long to motivate 
workers to submit services of good quality. 
5.2.2 Customer Focus and Quality Assurance 
The second study objective was evaluating the effect of customer focus on quality assurance 
of pharmaceutical distributors in the county of Nairobi. The study outcomes portrayed that the 
presence of systems for approval of changes which might be of effect on the quality of 
pharmaceutical products. Similarly, Stahl (2015) revealed that the constant of ways of bettering 
service or product quality can curb the occurrence of a problem in future.  There is a system 
present for recalling a batch of pharmaceutical products from supply or sale. The 
pharmaceutical distributors always examine the causes of quality defects on the pharmaceutical 
products and that all measures and decisions made arising from a complaint are documented 
and then references made to the conforming batch numbers. Consistent to the findings, 
Cheroigin (2014) found that performance and total quality management of the multinational 
pharmaceutical entities is determined by customer focus through meeting the customers’ 
needs.  
The pharmaceutical distributors have procedures for self-inspection and/or quality audit that 
regularly appraises the effectiveness of distribution system and written procedures are in place 
for the handling of customer complaints. Customer suggestion box are also available at the 
facilities. The Pharmaceutical Distributors has enhanced customer satisfaction and met their 
expectation based on the services offered by the facilities by ensuring timely delivery of 
customer products, timely response to customer complains, offering quality services, utilizing 
customer suggestion box, quick response to product quality defects and ensuring there are no 
counterfeits products. Forza and Filippini (2015) gave an explanation that its key for a firm to 
keep a close relation with the clients so as to be aware of what they need and evaluate how 
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effective it has been in satisfying the needs of clients. The above findings also relate to 
Resource-Based View theory which explores the role of key resources, identified as intangible 
assets and capabilities, in creating competitive advantage and superior performance. It 
emphasizes on the assets of the organization as being the important determining factors of 
implementation and enhancement of quality assurance. The theory relates to customer focus 
since customers are viewed as a significant component of an organization’s’ asset. The main 
objective of RBV stems from generating competitive advantage that enables companies to 
obtain quality assurance levels based upon their respective combination of resources and 
capacities which focuses on the need of the customers. 
5.2.3 Continuous Improvement and Quality Assurance 
The third objective was to assess the effect of continuous improvement on quality assurance 
of pharmaceutical distributors in Nairobi County. The study established that the 
Pharmaceutical Distributors undertakes regular trainings on employees to improve their skills 
and competences. They undertake quality audits and evaluation to enhance its quality 
assurance. There is a system in place to reduce the number of quality defects resulting from 
transportation. Regular departmental and employee appraisals are performed to measure 
employee performance. Consistent to the findings Oakland (2013) found that the attention on 
constant improvement will result to quality assurance by information of a difficult team 
whereby membership is measured by their job on the comprehensive comprehension of the 
procedure. The pharmaceutical distributors evaluate the performance of suppliers to enhance 
its quality assurance while a sectional department is in place to assess the effectiveness of the 
distribution system. 
The findings determined that the pharmaceutical distributors have made innovations and 
improvements to their facilities and processes to ensure quality assurance are achieved. The 
innovations and improvements made were; adoption of E-business, automation of stock 
control, implementation of electronic procurement system, regular employee training, 
technology adoption as well as having diverse designating systems and distribution control 
systems. Consistent to the findings Stahl (2015) established that continuous improvements 
done thought innovations and organizational system. The above findings relate to quality 
improvement theory put across by (Deming, 1986) which suggest that continuous 
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improvement gives an organization a plan of taking out low issues on quality control by 
effective systems of administration. The quality improvement theory advocates that for there 
to be quality assurance there must be continuous improvement of the processes and distribution 
systems in the organization. Quality Improvement theory alludes to constant improvement and 
refinement of the system of the organization, the services and goods of the firm to produce 
better value for clients. 
5.3 Conclusion 
The research established that management commitment took a significant role on quality 
assurance of pharmaceutical distributors in Nairobi County. The pharmaceutical distributors 
had codes of practice in place regarding employees involved in the distribution of 
pharmaceutical products and budget for quality assurance aspects. The interrelationships of all 
personnel participating in distribution of pharmaceutical products is clearly stated and their 
responsibilities are clearly stated.  
Customer focus, impacted significantly on quality assurance of pharmaceutical distributors in 
Nairobi County. Systems for change approval which could be of impact over the quality of 
pharmaceutical products and recalling a batch of pharmaceutical products from sale or supply 
are put in place. The pharmaceutical distributors had enhanced customer satisfaction and met 
their expectation based on the services offered by the facilities by ensuring timely delivery of 
customer products and responding to product quality defects and ensuring there are no 
counterfeits products.   
The pharmaceutical distributors undertook regular trainings on employees to improve their 
skills and competences and quality audits and evaluation to enhance its quality assurance. 
Systems are put in place to reduce the number of quality defects resulting from transportation. 
The pharmaceutical distributors have made innovations and improvements to their facilities 
and processes to ensure quality assurance are achieved.  
5.4 Recommendations 
The recommendations that follow are discussed according to the outcomes of the study; 
The study concludes that management commitment had a significant role on quality assurance 
of pharmaceutical distributors in Nairobi County. The research therefore recommends that 
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more funds should be allocated towards enhancing management commitment. The 
management should as well involve the employees in formulating and implementing the 
quality assurance strategies to overcome their resistance. 
Customer focus was discovered as having a significant impact over quality assurance of 
pharmaceutical distributors and as such, the study recommends that pharmaceutical 
distributors should continue ensuring customer satisfaction by ensuring timely delivery of 
customer products, timely response to customer complaints, offering quality services and quick 
response to product quality defects. 
The research gives a recommendation that pharmaceutical distributors should improve the 
quality assurance of the services and products offered by allocating more funds to quality 
assurance processes, developing well elaborate procedures, automation of processes, putting 
in place checks and balances and implementing recommendations of Pharmacy and Poisons 
Board. 
5.5 Suggestions for Further Studies 
The research determined the factors affecting quality assurance of pharmaceutical distributors 
in Nairobi County. The study however only focused on quality assurance at the distribution 
level of the pharmaceutical products. Further studies may be conducted on the factors affecting 
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Appendix I: Introduction Letter 
Dear Respondent, 
RE: Research Proposal 
I am a postgraduate student at Strathmore University pursuing a master of Business 
Administration Degree. I am carrying out a management research project aimed at determining 
THE FACTORS AFFECTING QUALITY ASSURANCE OF PHARMACEUTICAL 
DISTRIBUTORS IN NAIROBI COUNTY. The success of the research substantially 
depends on your cooperation. I hereby request you to respond to the questionnaire as honestly 
as possible and to the best of your knowledge. 
The questionnaire is designed for the purpose of this study only, therefore the responses will 
be treated confidentially and no name will be required from any respondent. 
 






Appendix II: Sample Questionnaire 
Kindly ticks in the space provided the correct answer or supply the required information where, 
required, please specify and elaborate. 
Part A: Respondents Information 
1 Name………………………………………………………………………. (Optional) 
 
2 Age of the respondent   (          ) 
 
3 Gender of the respondent? 
 Male                                                     Female       
 
4 What is your highest level of education? 
Postgraduate                 Degree              Diploma              
 




Part B: Management Commitment and Quality Assurance 
6 Please indicate the challenges faced by the top management in enhancing the quality 
assurance of the products and services? 
……………………………………………………………………………………………
…………………………………………………………………………………………… 
7 Indicate your level of agreement with the following statements that relate to influence of 
management commitment on quality assurance? Where: 1= Strongly agree; 2= Agree; 3= 
















































There is an organizational structure regarding the 
distribution of our pharmaceutical products 
     
The employees’ responsibility participating in 
distribution of pharmaceutical products is clearly 
stated in a job description 
     
The authority of all personnel participating in 
distribution of pharmaceutical products is clearly 
stated 
     
The interrelationships of all personnel participating in 
distribution of pharmaceutical products is clearly 
stated 
     
There is a business continuity plan to mitigate 
contingencies and natural disasters such as fire 
     
The distributor has a budget for Quality Assurance 
aspects such as redesigning the warehouse or 
investing in refrigerated vehicles 
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There is a code of practice in place regarding 
employees involved in the distribution of 
pharmaceutical products 
     
The distributor conducts risk assessments for 
measuring the probable risks towards the quality and 
integrity of the pharmaceutical products 
     
Part C:  Customer Focus and Quality Assurance 
8 Please indicate in what ways your facility has enhanced customer satisfaction and met 




9 Indicate your level of agreement with the following statements that relate to influence of 
customer focus on quality assurance. Where: 1= Strongly agree; 2= Agree; 3= Neutral; 
















































There is an existing documented procedure for 
handling complaints by customers 
     
There is a customer suggestion box at the facility       
The is no supply or selling of pharmaceutical 
products ahead of authorization 
     
There’s a process for quality auditing or  self-
inspection which frequently assesses the success 
of the distribution system  
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There exists a system that approves changes 
which might be having an effect on the quality of 
pharmaceutical products 
     
There is a system present for recalling a batch of 
pharmaceutical products from supply or sale 
     
We always investigate the causes of quality 
defects on the pharmaceutical products 
     
All measures and decisions made arising from a 
complaint are documented and then references 
made to the conforming batch numbers. 
     
 
Part D:  Continuous Improvement and Quality Assurance 
10 Please indicate the innovations and improvements made to your facility and processes to 




11 Indicate your level of agreement with the following statements that relate to influence of 
continuous improvement on quality assurance? Where: 1= Strongly agree; 2= Agree; 3= 
















































The Distributor undertakes quality audits and evaluation 
so as to enhance its quality assurance 
     
There is a sectional department in place to assess the 
effectiveness of your distribution system 
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The Distributor evaluates the performance of suppliers 
so as to enhance its quality assurance 
     
The Distributor undertakes regular trainings on 
employees so as to improve their skills and competences  
     
Regular departmental and employee appraisals are 
carried out to measure employee performance 
     
There is a system in place to reduce the number of 
quality defects resulting from transportation 






Part E: Quality Assurance 
12 Please indicate ways in which you can enhance the quality assurance of the services and 




13 Indicate your level of agreement with the following statements that relate to quality 
assurance in your facility? Where: 1= Strongly agree; 2= Agree; 3= Neutral; 4= Disagree; 
















































Our company has a quality assurance manager      
Our company has a quality manual for implementing 
the QA programmes 
     
Our company has developed the standard operating 
procedures (SOPs)  
     
Management commitment is the key factor in 
enhancing quality assurance at the Distributor 
     
Customer focus is the key factor in enhancing quality 
assurance at the Distributor 
     
Continuous improvement is the key factor in 
enhancing quality assurance at the Distributor. 
     
 
THANK YOU 
